Updates on Kawasaki Disease
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 94
Special Issue Editor
Special Issue Information
Dear Colleagues,
Kawasaki disease, first described by Dr. Tomisaku Kawasaki in 1967, is a febrile systemic vasculitis that primarily affects infants and young children. The development of coronary artery aneurysms, the most serious complication, can lead to acute coronary events such as myocardial infarction. Thanks to the development of acute treatments, the incidence of coronary sequelae in Japan remains at 2–3%, but the development of treatments aimed at eliminating all instances of coronary artery aneurysms is desirable. In recent years, according to a report by Burns et al., data-driven analysis has revealed that Kawasaki disease can be divided into four clusters, each with individual characteristics such as age at onset, response to treatment, and risk of coronary artery aneurysm. Based on these findings, we recognize that individualizing treatment methods for each cluster will be important in preventing future coronary artery aneurysm complications. We hope that this Special Issue will lead to future advances in the acute management and individualized treatment of Kawasaki disease.
Dr. Eisuke Suganuma
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- coronary artery aneurysm
- cluster
- individualized treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
